# Myers Industries Inc: financial statements, quarterly

MYE · NYSE · CIK 69488 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mye.md) · [Financials](/companies/mye/financials.md) · [Filings](/companies/mye/filings.md) · [Insiders](/companies/mye/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mye/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [198](/filings/0000950170-24-120691.md) | [191 d](/filings/0001193125-26-092521.md) | [207](/filings/0000950170-25-061811.md) | [220](/filings/0000950170-25-100886.md) | [205](/filings/0001193125-25-258507.md) | [204 d](/filings/0001193125-26-092521.md) | [162](/filings/0001193125-26-210311.md) | [163](/filings/0001193125-26-324876.md) | [205](/filings/0001193125-25-258507.md) | [204 d](/filings/0001193125-26-092521.md) | [165](/filings/0001193125-26-210311.md) | [179](/filings/0001193125-26-324876.md) |
| Cost of revenue | $m | [135](/filings/0000950170-24-120691.md) | [134 d](/filings/0001193125-26-092521.md) | [143](/filings/0000950170-25-061811.md) | [145](/filings/0000950170-25-100886.md) | [140](/filings/0001193125-25-258507.md) | [138 d](/filings/0001193125-26-092521.md) | [111](/filings/0001193125-26-210311.md) | [112](/filings/0001193125-26-324876.md) | [137](/filings/0001193125-25-258507.md) | [136 d](/filings/0001193125-26-092521.md) | [108](/filings/0001193125-26-210311.md) | [118](/filings/0001193125-26-324876.md) |
| Gross profit | $m | [62.4](/filings/0000950170-24-120691.md) | [57.2 d](/filings/0001193125-26-092521.md) | [64.3](/filings/0000950170-25-061811.md) | [75.5](/filings/0000950170-25-100886.md) | [65.1](/filings/0001193125-25-258507.md) | [65.9 d](/filings/0001193125-26-092521.md) | [50.2](/filings/0001193125-26-210311.md) | [51.1](/filings/0001193125-26-324876.md) | [68.6](/filings/0001193125-25-258507.md) | [67.7 d](/filings/0001193125-26-092521.md) | [56.5](/filings/0001193125-26-210311.md) | [61.5](/filings/0001193125-26-324876.md) |
| Selling, general and administrative | $m | [43.7](/filings/0000950170-24-120691.md) | [19.2 d](/filings/0001193125-26-092521.md) | [47.1](/filings/0000950170-25-061811.md) | [44.1](/filings/0000950170-25-100886.md) | [38.5](/filings/0001193125-25-258507.md) | [44.3 d](/filings/0001193125-26-092521.md) | [29.3](/filings/0001193125-26-210311.md) | [27.4](/filings/0001193125-26-324876.md) | [44.4](/filings/0001193125-25-258507.md) | [39.9 d](/filings/0001193125-26-092521.md) | [28.0](/filings/0001193125-26-210311.md) | [26.6](/filings/0001193125-26-324876.md) |
| Operating income | $m | [18.7](/filings/0000950170-24-120691.md) | [18.6 d](/filings/0001193125-26-092521.md) | [10.9](/filings/0000950170-25-061811.md) | [23.7](/filings/0000950170-25-100886.md) | [(4.8)](/filings/0001193125-25-258507.md) | [14.6 d](/filings/0001193125-26-092521.md) | [17.2](/filings/0001193125-26-210311.md) | [19.8](/filings/0001193125-26-324876.md) | [17.7](/filings/0001193125-25-258507.md) | [20.2 d](/filings/0001193125-26-092521.md) | [24.9](/filings/0001193125-26-210311.md) | [31.2](/filings/0001193125-26-324876.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.4](/filings/0000950170-24-120691.md) | [4.7 d](/filings/0001193125-26-092521.md) | [1.3](/filings/0000950170-25-061811.md) | [4.4](/filings/0000950170-25-100886.md) | [(2.0)](/filings/0001193125-25-258507.md) | [2.6 d](/filings/0001193125-26-092521.md) | [2.6](/filings/0001193125-26-210311.md) | [2.9](/filings/0001193125-26-324876.md) | [3.1](/filings/0001193125-25-258507.md) | [1.7 d](/filings/0001193125-26-092521.md) | [4.4](/filings/0001193125-26-210311.md) | [6.2](/filings/0001193125-26-324876.md) |
| Net income | $m | [12.7](/filings/0000950170-24-120691.md) | [12.5 d](/filings/0001193125-26-092521.md) | [3.5](/filings/0000950170-25-061811.md) | [10.3](/filings/0000950170-25-100886.md) | [(10.9)](/filings/0001193125-25-258507.md) | [4.3 d](/filings/0001193125-26-092521.md) | [6.8](/filings/0001193125-26-210311.md) | [9.7](/filings/0001193125-26-324876.md) | [7.1](/filings/0001193125-25-258507.md) | [11.3 d](/filings/0001193125-26-092521.md) | [(1.8)](/filings/0001193125-26-210311.md) | [20.0](/filings/0001193125-26-324876.md) |
| Diluted EPS | $ per share | [0.34](/filings/0000950170-24-120691.md) | not reported | [0.09](/filings/0000950170-25-061811.md) | [0.28](/filings/0000950170-25-100886.md) | [(0.29)](/filings/0001193125-25-258507.md) | not reported | [0.18](/filings/0001193125-26-210311.md) | [0.26](/filings/0001193125-26-324876.md) | [0.19](/filings/0001193125-25-258507.md) | not reported | [(0.05)](/filings/0001193125-26-210311.md) | [0.53](/filings/0001193125-26-324876.md) |
| Basic EPS | $ per share | [0.35](/filings/0000950170-24-120691.md) | not reported | [0.09](/filings/0000950170-25-061811.md) | [0.28](/filings/0000950170-25-100886.md) | [(0.29)](/filings/0001193125-25-258507.md) | not reported | [0.18](/filings/0001193125-26-210311.md) | [0.26](/filings/0001193125-26-324876.md) | [0.19](/filings/0001193125-25-258507.md) | not reported | [(0.05)](/filings/0001193125-26-210311.md) | [0.53](/filings/0001193125-26-324876.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [24.8](/filings/0000950170-23-057417.md) | [30.3](/filings/0000950170-25-034598.md) | [32.7](/filings/0000950170-24-054453.md) | [37.3](/filings/0000950170-24-089272.md) | [29.7](/filings/0000950170-24-120691.md) | [32.2](/filings/0001193125-26-092521.md) | [35.3](/filings/0000950170-25-061811.md) | [41.3](/filings/0000950170-25-100886.md) | [48.0](/filings/0001193125-25-258507.md) | [40.5](/filings/0001193125-26-324876.md) | [44.6](/filings/0001193125-26-210311.md) | [47.6](/filings/0001193125-26-324876.md) |
| Current assets | $m | [247](/filings/0000950170-23-057417.md) | [257](/filings/0000950170-25-034598.md) | [284](/filings/0000950170-24-054453.md) | [296](/filings/0000950170-24-089272.md) | [275](/filings/0000950170-24-120691.md) | [259](/filings/0001193125-26-092521.md) | [289](/filings/0000950170-25-061811.md) | [276](/filings/0000950170-25-100886.md) | [287](/filings/0001193125-25-258507.md) | [281](/filings/0001193125-26-324876.md) | [300](/filings/0001193125-26-210311.md) | [314](/filings/0001193125-26-324876.md) |
| Total assets | $m | [531](/filings/0000950170-23-057417.md) | [542](/filings/0001193125-26-092521.md) | [947](/filings/0000950170-25-061811.md) | [952](/filings/0000950170-25-100886.md) | [905](/filings/0001193125-25-258507.md) | [861](/filings/0001193125-26-092521.md) | [884](/filings/0000950170-25-061811.md) | [863](/filings/0000950170-25-100886.md) | [864](/filings/0001193125-25-258507.md) | [853](/filings/0001193125-26-324876.md) | [837](/filings/0001193125-26-210311.md) | [845](/filings/0001193125-26-324876.md) |
| Current liabilities | $m | [164](/filings/0000950170-23-057417.md) | [165](/filings/0000950170-25-034598.md) | [162](/filings/0000950170-24-054453.md) | [164](/filings/0000950170-24-089272.md) | [153](/filings/0000950170-24-120691.md) | [147](/filings/0001193125-26-092521.md) | [163](/filings/0000950170-25-061811.md) | [156](/filings/0000950170-25-100886.md) | [172](/filings/0001193125-25-258507.md) | [169](/filings/0001193125-26-324876.md) | [182](/filings/0001193125-26-210311.md) | [195](/filings/0001193125-26-324876.md) |
| Total liabilities | $m | [249](/filings/0000950170-23-057417.md) | [249](/filings/0000950170-25-034598.md) | [655](/filings/0000950170-24-054453.md) | [657](/filings/0000950170-24-089272.md) | [629](/filings/0000950170-24-120691.md) | [583](/filings/0001193125-26-092521.md) | [606](/filings/0000950170-25-061811.md) | [578](/filings/0000950170-25-100886.md) | [577](/filings/0001193125-25-258507.md) | [558](/filings/0001193125-26-324876.md) | [548](/filings/0001193125-26-210311.md) | [539](/filings/0001193125-26-324876.md) |
| Long-term debt | $m | [34.0](/filings/0000950170-23-057417.md) | [32.0](/filings/0000950170-25-034598.md) | [381](/filings/0000950170-24-054453.md) | [380](/filings/0000950170-24-089272.md) | [368](/filings/0000950170-24-120691.md) | [355](/filings/0001193125-26-092521.md) | [364](/filings/0000950170-25-061811.md) | [346](/filings/0000950170-25-100886.md) | [332](/filings/0001193125-25-258507.md) | [311](/filings/0001193125-26-324876.md) | [292](/filings/0001193125-26-210311.md) | [272](/filings/0001193125-26-324876.md) |
| Current portion of debt | $m | [26.0](/filings/0000950170-23-057417.md) | [26.0](/filings/0000950170-25-034598.md) | [19.6](/filings/0000950170-24-054453.md) | [19.6](/filings/0000950170-24-089272.md) | [19.6](/filings/0000950170-24-120691.md) | [19.6](/filings/0001193125-26-092521.md) | [19.6](/filings/0000950170-25-061811.md) | [24.6](/filings/0000950170-25-100886.md) | [29.5](/filings/0001193125-25-258507.md) | [34.6](/filings/0001193125-26-324876.md) | [39.4](/filings/0001193125-26-210311.md) | [39.5](/filings/0001193125-26-324876.md) |
| Shareholders' equity | $m | [282](/filings/0000950170-24-120691.md) | [293](/filings/0001193125-26-092521.md) | [292](/filings/0000950170-25-100886.md) | [295](/filings/0001193125-25-258507.md) | [276](/filings/0001193125-25-258507.md) | [278](/filings/0001193125-26-324876.md) | [277](/filings/0001193125-26-324876.md) | [285](/filings/0001193125-26-324876.md) | [287](/filings/0001193125-25-258507.md) | [294](/filings/0001193125-26-324876.md) | [289](/filings/0001193125-26-324876.md) | [306](/filings/0001193125-26-324876.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.1 d](/filings/0000950170-24-120691.md) | [15.4 d](/filings/0001193125-26-092521.md) | [20.3](/filings/0000950170-25-061811.md) | [14.3 d](/filings/0000950170-25-100886.md) | [17.3 d](/filings/0001193125-25-258507.md) | [27.3 d](/filings/0001193125-26-092521.md) | [10.1](/filings/0001193125-26-210311.md) | [28.3 d](/filings/0001193125-26-324876.md) | [25.8 d](/filings/0001193125-25-258507.md) | [22.6 d](/filings/0001193125-26-092521.md) | [26.2](/filings/0001193125-26-210311.md) | [33.5 d](/filings/0001193125-26-324876.md) |
| Capital expenditure | $m | [4.1 d](/filings/0000950170-24-120691.md) | [3.6 d](/filings/0001193125-26-092521.md) | [5.7](/filings/0000950170-25-061811.md) | [4.4 d](/filings/0000950170-25-100886.md) | [7.2 d](/filings/0001193125-25-258507.md) | [7.1 d](/filings/0001193125-26-092521.md) | [8.0](/filings/0001193125-26-210311.md) | [3.6 d](/filings/0001193125-26-324876.md) | [4.3 d](/filings/0001193125-25-258507.md) | [3.6 d](/filings/0001193125-26-092521.md) | [2.8](/filings/0001193125-26-210311.md) | [5.6 d](/filings/0001193125-26-324876.md) |
| Dividends paid | $m | [5.0 d](/filings/0000950170-24-120691.md) | [5.0 d](/filings/0001193125-26-092521.md) | [5.3](/filings/0000950170-25-061811.md) | [5.0 d](/filings/0000950170-25-100886.md) | [5.0 d](/filings/0001193125-25-258507.md) | [5.0 d](/filings/0001193125-26-092521.md) | [5.3](/filings/0001193125-26-210311.md) | [5.1 d](/filings/0001193125-26-324876.md) | [5.1 d](/filings/0001193125-25-258507.md) | [5.1 d](/filings/0001193125-26-092521.md) | [5.1](/filings/0001193125-26-210311.md) | [5.2 d](/filings/0001193125-26-324876.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0000950170-25-061811.md) | [0.0 d](/filings/0000950170-25-100886.md) | [0.0 d](/filings/0001193125-25-258507.md) | [0.0 d](/filings/0001193125-26-092521.md) | [1.0](/filings/0001193125-26-210311.md) | [0.5 d](/filings/0001193125-26-324876.md) | [0.5 d](/filings/0001193125-25-258507.md) | [0.5 d](/filings/0001193125-26-092521.md) | [0.0](/filings/0001193125-26-210311.md) | [0.0 d](/filings/0001193125-26-324876.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [36.7](/filings/0000950170-23-057417.md) | [36.8](/filings/0000950170-24-054453.md) | [36.9](/filings/0000950170-24-089272.md) | [37.0](/filings/0000950170-24-120691.md) | [37.1](/filings/0000950170-25-061811.md) | [37.3](/filings/0000950170-25-100886.md) | [37.2](/filings/0001193125-25-258507.md) | [37.4](/filings/0001193125-26-210311.md) | [37.4](/filings/0001193125-26-324876.md) | [37.6](/filings/0001193125-25-258507.md) | [37.7](/filings/0001193125-26-210311.md) | [37.8](/filings/0001193125-26-324876.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,618,070 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001193125-26-324876.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.